ArticleJournal of interventional medicine2022
Complications from port-a-cath system implantation in adults with malignant tumors: A 10-year single-center retrospective study.
Article in Journal of interventional medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.
- [Clinical Practice and Quality Control Guidelines for Totally Implantable Venous Access Ports in Cancer Patients (2024)].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025Guideline
- Complications of Port-a-Cath Systems: An Institutional Study on Romanian Oncological Patients.Cancers · 2026Article
- Prospective study of the behavior of totally implantable catheters in female oncology patients with mammary hypertrophy.Einstein (Sao Paulo, Brazil) · 2026Article
- Indian Expert Consensus on the Selection of Vascular Access Devices in Oncology Patients.Indian journal of surgical oncology · 2025Article
- Experience with the implementation of central venous catheters by medical oncologists in a non-surgical setting.Scientific reports · 2025Observational
- Expert consensus on the clinical application of totally implantable venous access devices in the upper arm (2022 Edition).Journal of interventional medicine · 2023Article
- Intravascular treatment for abnormal catheter positioning of port-a-cath system in the subclavian vein: A single-center study.Journal of interventional medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Port-A-Cath systems (PCS) are safe and convenient devices for long-term infusion in patients with malignant tumors. This study retrospectively analyzed the complications from PCS and their management. Methods: Data of 1695 adults (641 males and 1054 females) with malignant tumors who underwent PCS implantation in our center from January 1, 2009 to December 31, 2019 who had complete follow-up records were collected in this study. The early and late complications and corresponding treatments were studied. Results: A total of 1716 PCSs were implanted; 21 patients underwent 2 implantations each. The success rate was 100% and no severe complications occurred during implantation. The overall occurrence rate of post-implantation complications was 18.5% (318/1716); 5.5% (94/1716) were early complications and 13.0% (224/1716) were late complications. A total of 451 PCSs were removed, of which 398 were removed due to the end of chemotherapy, while 53 were removed because of complications. A total of 4 deaths occurred from these complications. Conclusions: The incidence of intra- and post-operative complications is low. In most cases, complications can be effectively controlled without the removal of the PCS and regular follow-up and maintenance are critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.